Walgreens Boots earnings beat by $0.12, revenue topped estimates

Walgreens Boots (NASDAQ: WBA ) reported first quarter EPS of $0.510, $0.12 better than the analyst estimate of $0.390. Revenue for the quarter came in at $39.46B versus the consensus estimate of $37.35B. Guidance

Walgreens Boots sees FY 2025 EPS of $1.400-$1.800 versus the analyst consensus of $1.530.







Walgreens Boots's stock price closed at $9.22. It is up 2.440% in the last 3 months and down -61.630% in the last 12 months.

Walgreens Boots saw 1 positive EPS revisions and 9 negative EPS revisions in the last 90 days. See Walgreens Boots's stock price’s past reactions to earnings here.

According to InvestingPro, Walgreens Boots's Financial Health score is "weak performance".

Check out Walgreens Boots's recent earnings performance , and Walgreens Boots's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Source: Investing.com

Последние публикации
US stocks slump after strong payrolls; Nasdaq sinks 1.5%
10.01.2025 - 17:01
Joby Aviations shares sink after JPMorgan downgrades to Underweight
10.01.2025 - 17:00
Insurer shares slip as analysts eye possible costs of LA wildfires
10.01.2025 - 17:00
Greece examines impact of US blacklisting of Piraeus port owner COSCO - sources
10.01.2025 - 17:00
RBC cautious on Homebuilders, prefers select building products
10.01.2025 - 17:00
Lululemon upgraded to Buy at Needham as U.S. trends re-accelerating
10.01.2025 - 17:00
US insurers slump as Los Angeles wildfire loss estimates hit $20 billion
10.01.2025 - 17:00
Ethiopia launches stock exchange in fresh step to liberalise economy
10.01.2025 - 17:00
BMO upgrades Atlassian to 'outperform' on growth confidence
10.01.2025 - 17:00
Ströer SE considers selling core ad business for $4.1 billion, Bloomberg reports
10.01.2025 - 17:00
Constellation Energy to buy Calpine in blockbuster $16.4 billion U.S. power deal
10.01.2025 - 17:00
JPMorgan asks staff to return to office five days a week in March, memo shows
10.01.2025 - 17:00
Intra-Cellular Therapies stock climbs on patent litigation settlement
10.01.2025 - 17:00
UK gilt selloff triggers pension cash calls in first big test since 2022 crisis
10.01.2025 - 17:00
Fed unlikely to cut rates anytime soon after strong jobs report, deVere Group CEO says
10.01.2025 - 17:00

© Analytic DC. All Rights Reserved.

new
Анализ рынка Как повлият завтра отчет NFP на курс доллара США?